Male erectile dysfunction: Integrating psychopharmacology and psychotherapy

General Hospital Psychiatry

Volumn 35, Issue 1, 2013, Pages 33-38

  Simopoulos, Eugene F ^a   Trinidad, Anton C ^a  

^a GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

Author keywords

Erectile dysfunction Psychopharmacology; Psychotherapy; Sexual dysfunction

Indexed keywords

ALPRAZOLAM; AMANTADINE; ARIPIPRAZOLE; ATYPICAL ANTIPSYCHOTIC AGENT; BENZODIAZEPINE; BROMOCRIPTINE; BUSPIRONE; CABERGOLINE; CLOZAPINE; CYPROHEPTADINE; DOPAMINE 2 RECEPTOR BLOCKING AGENT; FLUOXETINE; FLUVOXAMINE; HALOPERIDOL; METHYLPHENIDATE; NEUROLEPTIC AGENT; OLANZAPINE; PAROXETINE; PHOSPHODIESTERASE V INHIBITOR; PLACEBO; QUETIAPINE; RISPERIDONE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; SILDENAFIL; TADALAFIL; UNINDEXED DRUG; VARDENAFIL; VENLAFAXINE; YOHIMBINE;

ABDOMINAL PAIN; AGITATION; ANXIETY; ANXIETY DISORDER; ARTICLE; CONFUSION; CONSTIPATION; DEPRESSION; DISEASE ASSOCIATION; DISEASE EXACERBATION; DIZZINESS; DRUG BLOOD LEVEL; DRUG CONTRAINDICATION; DRUG HALF LIFE; DRUG INDUCED HEADACHE; DRUG MEGADOSE; DRUG SAFETY; DRUG TOLERABILITY; DYSPEPSIA; ERECTILE DYSFUNCTION; FATIGUE; FEMALE SEXUAL DYSFUNCTION; FLUSHING; HALLUCINATION; HUMAN; HYPERPROLACTINEMIA; INSOMNIA; LIBIDO DISORDER; MAJOR DEPRESSION; MALE; MALE SEXUAL DYSFUNCTION; MEN'S HEALTH; NAUSEA; NOSE OBSTRUCTION; ORGASM DISORDER; ORTHOSTATIC HYPOTENSION; PANIC; PATIENT COMPLIANCE; PRIAPISM; PSYCHOPHARMACOLOGY; PSYCHOSIS; PSYCHOTHERAPY; QUALITY OF LIFE; RECOMMENDED DRUG DOSE; SCHIZOPHRENIA; SEXUAL BEHAVIOR; SEXUAL HEALTH; SEXUAL SATISFACTION; SIDE EFFECT; SOMNOLENCE; SUBSTANCE ABUSE; TREATMENT OUTCOME; VASODILATATION; VOMITING;

ANTIDEPRESSIVE AGENTS; COMBINED MODALITY THERAPY; DEPRESSION; ERECTILE DYSFUNCTION; HUMANS; MALE; PHOSPHODIESTERASE 5 INHIBITORS; PSYCHOTHERAPY; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; SEXUAL DYSFUNCTIONS, PSYCHOLOGICAL;

EID: 84872404720     PISSN: 01638343     EISSN: 18737714     Source Type: Journal    
DOI: 10.1016/j.genhosppsych.2012.08.008     Document Type: Article

References (43)

1. Carson C., Mcmahon C. Fast facts: erectile dysfunction 2008, Health Press Limited, Oxford. 4th ed.
2. Aytac I.A., McKinlay J.B., Krane R.J. The likely worldwide increase in erectile dysfunction between 1995 and 2025 and some possible policy consequences. BJU Int 1999, 84:50-56.
3. Bacon C.G., Mittleman M.A., Kawachi I., et al. Sexual function in men older than 50 years of age: results from the health professionals follow-up study. Ann Intern Med 2003, 139(3):161-168.
4. Feldman H.A., Goldstein I., Hatzichristou D.G., et al. Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study. J Urol 1994, 151:54-61.
5. Carson C., Lue T. Great drug classes: phosphodiesterase type 5 inhibitors for erectile dysfunction. BJU Int 2005, 96(3):262-263.
6. Montague D., Jarow J., Broderick G., et al. The management of erectile dysfunction: an AUA update. J Urol 2005, 174:231.
7. Levine L. Diagnosis and treatment of erectile dysfunction. Am J Med 2000, 109(9):6S.
8. Kennedy S., Rizvi S. Sexual dysfunction, depression, and the impact of antidepressants. J Clin Psychopharmacol 2009, 29(2):157-161.
9. Mathew R., Weinman M. Sexual dysfunctions in depression. Arch Sex Behav 1982, 11:323-328.
10. Angst J. Sexual problems in healthy and depressed patients. Int Clin Pharmacol 1998, 13:S1-S4.
11. Araujo A.B., Durante R., Feldman H.A., et al. The relationship between depressive symptoms and male erectile dysfunction: cross-sectional results from the Massachusetts Male Aging Study. Psychosom Med 1998, 60:458-465.
12. Kennedy S., Dickens S., Eisfeld B., et al. Sexual dysfunction before antidepressant therapy in major depression. J Affect Disord 1999, 56:201-208.
13. Bonierbale M., Lancon C., Tignol J. The ELIXIR study: evaluation of sexual dysfunction in 4557 depressed patients in France. Curr Med Res Opin 2003, 19:114-123.
14. Althof S. Depression and erectile dysfunction. Men's Sexual Health Consult Collection 2006, 29-34.
15. Montejo A., Llorca G., Izquierdo J., Rico-Villademoros F. Incidence of sexual dysfunction associated with antidepressant agents: a prospective multicenter study of 1022 outpatients. J Clin Psychiatry 2001, 62:10-21.
16. Clayon K., McGarvey E. Burden of phase-specific sexual dysfunction with SSRIs. J Affect Disord 2006, 91:27-32.
17. Landen M., Hogberg P., Thase M. Incidence of sexual side effects in refractory depression during treatment with citalopram or paroxetine. J Clin Psychiatry 2005, 66:100-106.
18. Pollack M.H., Reiter S., Hammerness P. Genitourinary and sexual adverse effects of psychotropic medication. Int J Psychiatry Med 1992, 22:305-327.
19. Ashton A.K., Hamer R., Rosen R.C. Serotonin reuptake inhibitor-induced sexual dysfunction and its treatment: a large-scale retrospective study of 596 psychiatric outpatients. J Sex Marital Ther 1997, 23:165-175.
20. Montejo-Gonzalez A.L., Llorca G., Izquierdo J.A. SSRI-induced sexual dysfunction: fluoxetine, paroxetine, sertraline, and fluvoxamine in a prospective, multi-center, and descriptive clinical study of 344 patients. J Sex Marital Ther 1997, 23:176-194.
21. Labbate L.A., Grimes J. Sexual dysfunction induced by serotonin reuptake antidepressants. J Sex Marital Ther 1998, 24:3-12.
22. Bitter I., Basson B.R., Dossenbach M.R. Antipsychotic treatment and sexual functioning in first-time neuroleptic-treated schizophrenic patients. Int Clin Psychopharmacol 2005, 20:19-21.
23. Dossenbach M.R., Hodge A., Anders M., et al. Prevalence of sexual dysfunction in patients with schizophrenia: international variation and underestimation. Int J Neuropsychopharmacol 2005, 8:195-201.
24. Olfson M., Uttaro T., Carson W.H., Tafesse E. Male sexual dysfunction and quality of life in schizophrenia. J Clin Psychiatry 2005, 66:331-338.
25. Smith S.M., O'Keane V., Murray R. Sexual dysfunction in patients taking conventional antipsychotic medication. Br J Psychiatry 2002, 181:49-55.
26. Lambert M., Conus P., Eide P., et al. Impact of present and past antipsychotic side effects on attitude toward typical antipsychotic treatment and adherence. Eur Psychiatry 2004, 19:415-422.
27. Sullivan G., Lukoff D. Sexual side effects of antipsychotic medication: evaluation and interventions. Hosp Community Psychiatry 1990, 41(11):1238-1241.
28. Knegtering H., Blijd C., Boks M. Sexual dysfunction and prolactin levels in patients using classical antipsychotics, risperidone or olanzapine. Schizophr Res 1999, 36(1-3):355-456.
29. Bobes J., Garc A-Portilla M.P., Rejas J., et al. Frequency of sexual dysfunction and other reproductive side-effects in patients with schizophrenia treated with risperidone, olanzapine, quetiapine, or haloperidol: the results of the EIRE study. J Sex Marital Ther 2003, 29(2):125-147.
30. Baggaley M. Sexual dysfunction in schizophrenia: focus on recent evidence. Hum Psychopharmacol Clin Exp 2008, 23:201-209.
31. Papakostas G.I., Petersen T.J., Kinrys G., et al. Aripiprazole augmentation of selective serotonin reuptake inhibitors for treatment-resistant major depressive disorder. J Clin Psychiatry 2005, 66:1326-1330.
32. Lydiard R., Howell E. Sexual side effects of alprazolam. Am J Psychiatry 1987, 144:254-255. [Letter].
33. Sadovsky R., Miller T., Moskowitz M., Hackett G. Three-year update of sildenafil citrate (Viagra) efficacy and safety. Int J Clin Pract 2001, 55:115-128.
34. Smith K., Romanelli F. Recreational use and misuse of phosphodiesterase 5 inhibitors. J Am Pharm Assoc 2005, 45(1):63-75.
35. Safarinejad M.R. The effects of the adjunctive bupropion on male sexual dysfunction induced by a selective serotonin reuptake inhibitor: a double-blind placebo-controlled and randomized study. BJU Int 2010, 106(6):840-847.
36. Labbate L., Fava M. Handbook of psychiatric drug therapy 2010, Lippincott Williams and Wilkins, Philadelphia. 6th ed.
37. Costa A.M., Silva De Lima M., De Jesus Mari J. A systematic review on clinical management of antipsychotic-induced sexual dysfunction in schizophrenia. Sao Paulo Med J 2006, 124(5):291-297.
38. Althof S. Sexual therapy in the age of pharmacotherapy. Annu Rev Sex Res 2006, 17:1-16.
39. Althof S., Wieder M. Psychotherapy for erectile dysfunction. now more relevant than ever. Endocrine 2004, 23(2-3):131-134.
40. Schover L. Prime time - sexual health for men over fifty 1984, Holt, Rinehart & Winston, New York.
41. Zilbergeld B. The new male sexuality 1999, Bantam, New York.
42. Rosen R., Leiblum S. I Spector. J Sex Marital Ther 1994, 20(2):67-85.
43. Melnik T., Soares B., Nasello A. The effectiveness of psychological interventions for the treatment of erectile dysfunction: systematic review and meta-analysis, including comparisons to sildenafil treatment, intracavernosal injection, and vacuum devices. J Sex Med 2008, 5:2562-2574.